cme.medlearning.de - CME Logo

Literatur

  1. Lin S, Schranz J, Teutsch S. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32:358-66.
  2. Jarvis WR. Epidemiology of nosocomial infections, with emphasis on Candida species. Clin Infect Dis 1995; 20:1526-1530.
  3. Samonis G, Bafaloukos D. Fungal infections in cancer patients: an escalating problem. In Vivo 1992; 6:183-193.
  4. Groll AH, Shah PM, Mentzel C et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33:23-32.
  5. Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M, Mall G, Martino P, Meunier F, Milliken S, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992; 11(2):99-109.
  6. Lin S, Schranz J, Teutsch S. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32:358-366.
  7. Singh N. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients. Lancet Infect Dis 2003 Mar;3(3):156-61
  8. R. Herbrecht, D. W. Denning, T. F. Patterson, J. E. Bennett, R. E. Greene, J. W. Oestmann, W. V. Kern, K. A. Marr, P. Ribaud, O. Lortholary, R. Sylvester, R. H. Rubin, J. R. Wingard, P. Stark, C. Durand, D. Caillot, E. Thiel, P. H. Chandrasekar, M. R. Hodges, H. T. Schlamm, P. F. Troke, and B. E. de Pauw. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415., 2002.
  9. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175:1459-1466.
  10. Sherertz RJ, Belani A, Kramer BS, Elfenbein GJ, Weiner RS, Sullivan ML, et al. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 1987; 83:709-718.
  11. Jantunen E, Piilonen A, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T, et al. Diagnostic aspects of invasive aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000; 25:867-871.
  12. Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, et al. Practice guidelines for diseases caused by aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000; 30:696-709.
  13. W. W. Hope, T. J. Walsh, and D. W. Denning. The invasive and saphrophytic syndromes due to Aspergillus spp. Medical.Mycology. 43:S207-S238, 2005.
  14. Verweij PE, Brinkman K, Kullberg BJ, Meis JF. Uncertainities in invasive aspergillosis: Diagnostic strategy, particularly serology. Proceedings 38th ICCAC, San Diego 1998; 159J-S118. Abstract.
  15. Richardson MD, Kokki MH. New perspectives in the diagnosis of systemic fungal infections. Ann Med 1999; 31:327-335.
  16. Gerson SL, Talbot GH, Lusk E, Hurwitz S, Strom BL, Cassileth PA. Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis. J Clin Oncol 1985; 3:1109-1116.
  17. Denning DW. Invasive aspergillosis. Clinical Infectious Diseases 1998; 26:781-805.
  18. Hope WW, Walsh TJ, Denning DW. The invasive and saphrophytic syndromes due to Aspergillus spp. Medical Mycology 2005;43(Suppl. 1):S207-38.
  19. J. Maertens, J. Verhaegen, H. Demuynck, P. Brock, G. Verhoef, P. Vandenberghe, J. Van Eldere, L. Verbist, and M. Boogaerts. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J.Clin.Microbiol. 37 (10):3223-3228, 1999.
  20. Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005;41:1242-50. Epub 2005 Sep 29.
  21. J. Maertens, K. Theunissen, E. Verbeken, K. Lagrou, J. Verhaegen, J. Bogaerts, and J. V. Eldere. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004 Sep;126(6):852-60., 2004.
  22. H. Hebart, J. Loeffler, H. Reitze, A. Engel, U. Schumacher, T. Klingebiel, P. Bader, A. Böhme, H. Martin, D. Bunjes, W. V. Kern, L. Kanz, and H. Einsele. Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections. implications for the management of febrile neutropenia. Br.J.Haematol. 111 (2):635-640, 2000.
  23. D. Buchheidt, M. Hummel, D. Schleiermacher, B. Spiess, R. Schwerdtfeger, O. A. Cornely, S. Wilhelm, S. Reuter, W. Kern, T. Sudhoff, H. Morz, and R. Hehlmann. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br.J.Haematol. 125 (2):196-202, 2004.
  24. Ascioglu S, Rex JH, De-Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 Jan 1;34(1):7-14.
  25. J. R. Perfect, G. M. Cox, J. Y. Lee, C. A. Kauffman, L. de Repentigny, S. W. Chapman, V. A. Morrison, P. Pappas, J. W. Hiemenz, D. A. Stevens, and Mycosis Study Group. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clinical Infectious Diseases 33 (11):1824-133, 2001.
  26. Heussel CP, Kauczor HU, Heussel GE, Fischer B, Begrich M, Mildenberger P, et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 1999; 17:796-805.
  27. Gaeta M, Blandino A, Scribano E, Minutoli F, Volta S, Pandolfo I. Computed tomography halo sign in pulmonary nodules: frequency and diagnostic value. J Thorac Imaging 1999; 14:109-113.
  28. Won HJ, Lee KS, Cheon JE, Hwang JH, Kim TS, Lee HG, et al. Invasive pulmonary aspergillosis: prediction at thin-section ct in patients with neutropenia - a prospective study. Radiology 1998; 208:777-782.
  29. Caillot D, Casanovas O, Bernard A, Couallier JF, Durand C, Cuisenier B, Solari E, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15:139-147.
  30. Gefter WB, Albelda SM, Talbot GH, Gerson SL, Cassileth PA, Miller WT. Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent sign. Radiology 1985; 157:605-610.
  31. Todeschini G, Murari C, Bonesi R, Pizzolo G, Verlato G, Tecchio C, et al. Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest 1999; 29:453-457.